UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 671

Sortiert nach

Epigenetic regulation of somatostatin and somatostatin receptors in neuroendocrine tumors and other types of cancer

Reviews in endocrine & metabolic disorders, 2021-09, Vol.22 (3), p.495-510

2021

Volltextzugriff (PDF)

Midgut neuroendocrine tumor patients have a depleted gut microbiome with a discriminative signature

European journal of cancer (1990), 2024-01, Vol.197, p.113472-113472, Article 113472

2024

Volltextzugriff (PDF)

ROLE of IGF-1 System in the Modulation of Longevity: Controversies and New Insights From a Centenarians' Perspective

Frontiers in endocrinology (Lausanne), 2019-02, Vol.10, p.27-27

2019

Volltextzugriff (PDF)

Fluconazole inhibits human adrenocortical steroidogenesis in vitro

Journal of endocrinology, 2012-12, Vol.215 (3), p.403-412

2012

Volltextzugriff (PDF)

Adrenal Cushing's syndrome during pregnancy

European journal of endocrinology, 2017-11, Vol.177 (5), p.K13

2017

Volltextzugriff (PDF)

Evaluation of Spheroid 3D Culture Methods to Study a Pancreatic Neuroendocrine Neoplasm Cell Line

Frontiers in endocrinology (Lausanne), 2019-10, Vol.10, p.682-682

2019

Volltextzugriff (PDF)

Salvage peptide receptor radionuclide therapy with [177Lu-DOTA,Tyr3]octreotate in patients with bronchial and gastroenteropancreatic neuroendocrine tumours

European journal of nuclear medicine and molecular imaging, 2019-03, Vol.46 (3), p.704-717

2019

Volltextzugriff (PDF)

The Pathophysiological Consequences of Somatostatin Receptor Internalization and Resistance

Endocrine reviews, 2003-02, Vol.24 (1), p.28-47

2003

Volltextzugriff (PDF)

T2-signal intensity, SSTR expression, and somatostatin analogs efficacy predict response to pasireotide in acromegaly

European journal of endocrinology, 2020-06, Vol.182 (6), p.595

2020

Volltextzugriff (PDF)

Whole-exome characterization of pancreatic neuroendocrine tumor cell lines BON-1 and QGP-1

Journal of molecular endocrinology, 2015-04, Vol.54 (2), p.137-147

2015

Volltextzugriff (PDF)

Future directions in the diagnosis and medical treatment of adrenocortical carcinoma

Endocrine-related cancer, 2016-01, Vol.23 (1), p.R43-R69

2016

Volltextzugriff (PDF)

Interferon-beta enhances sensitivity to gemcitabine in pancreatic cancer

BMC cancer, 2020-09, Vol.20 (1), p.913-913, Article 913

2020

Volltextzugriff (PDF)

Peptide receptor radionuclide therapy in patients with medullary thyroid carcinoma: predictors and pitfalls

BMC cancer, 2019-04, Vol.19 (1), p.325-325, Article 325

2019

Volltextzugriff (PDF)

Long-Term Efficacy and Safety of Pegvisomant in Combination With Long-Acting Somatostatin Analogs in Acromegaly

The journal of clinical endocrinology and metabolism, 2014-10, Vol.99 (10), p.3644-3652

2014

Volltextzugriff (PDF)

Vandetanib versus Cabozantinib in Medullary Thyroid Carcinoma: A Focus on Anti-Angiogenic Effects in Zebrafish Model

International journal of molecular sciences, 2021-03, Vol.22 (6), p.3031

2021

Volltextzugriff (PDF)

Epigenetic regulation of SST2 expression in small intestinal neuroendocrine tumors

Frontiers in endocrinology (Lausanne), 2023-05, Vol.14, p.1184436-1184436

2023

Volltextzugriff (PDF)

How to Differentiate Benign from Malignant Adrenocortical Tumors?

Cancers, 2021-08, Vol.13 (17), p.4383

2021

Volltextzugriff (PDF)

Comparing the Effect of Multiple Histone Deacetylase Inhibitors on SSTR2 Expression and [111In]In-DOTATATE Uptake in NET Cells

Cancers, 2021-09, Vol.13 (19), p.4905

2021

Volltextzugriff (PDF)

Effect of epigenetic treatment on SST2 expression in neuroendocrine tumour patients

Clinical and translational medicine, 2022-07, Vol.12 (7), p.e957-n/a

2022

Volltextzugriff (PDF)

Reciprocal Interactions between Fibroblast and Pancreatic Neuroendocrine Tumor Cells: Putative Impact of the Tumor Microenvironment

Cancers, 2022-07, Vol.14 (14), p.3481

2022

Volltextzugriff (PDF)

Unfavorable biological behavior and treatment response of neuroendocrine ovarian metastases of midgut neuroendocrine tumors

Endocrine-related cancer, 2023-08, Vol.30 (8), p.1

2023

Volltextzugriff (PDF)

Influence of type‐I Interferon receptor expression level on the response to type‐I Interferons in human pancreatic cancer cells

Journal of cellular and molecular medicine, 2014-03, Vol.18 (3), p.492-502

2014

Volltextzugriff (PDF)

Preclinical Evaluation of Novel Tyrosine-Kinase Inhibitors in Medullary Thyroid Cancer

Cancers, 2022-09, Vol.14 (18), p.4442

2022

Volltextzugriff (PDF)

Intra-arterial peptide-receptor radionuclide therapy for neuro-endocrine tumour liver metastases: an in-patient randomised controlled trial (LUTIA)

European journal of nuclear medicine and molecular imaging, 2024-03, Vol.51 (4), p.1121-1132

2024

Volltextzugriff (PDF)

Effect of the Tryptophan Hydroxylase Inhibitor Telotristat on Growth and Serotonin Secretion in 2D and 3D Cultured Pancreatic Neuroendocrine Tumor Cells

Neuroendocrinology, 2020-04, Vol.110 (5), p.351-363

2020

Volltextzugriff (PDF)

1 – 25 von 671

Suche als RSS-Feed

Aktive Filter

ThemaEndocrinopathies

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(609)
Mit Volltextzugriff
(577)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(462)
Life Sciences & Biomedicine
(421)
Humans
(345)
Female
(175)
Male
(171)
Biological And Medical Sciences
(158)
Endocrinology & Metabolism
(154)
Medical Sciences
(124)
Animals
(122)
Middle Aged
(116)
Adult
(111)
Oncology
(102)
Aged
(86)
Tumors
(67)
Somatostatin - Analogs & Derivatives
(57)
Surgery
(53)
Rats
(51)
Receptors, Somatostatin - Metabolism
(50)
Somatostatin
(48)
Pharmacology. Drug Treatments
(47)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Epigenetic regulation of somatostatin and somatostatin receptors in neuroendocrine tumors and other types of cancer

Midgut neuroendocrine tumor patients have a depleted gut microbiome with a discriminative signature

ROLE of IGF-1 System in the Modulation of Longevity: Controversies and New Insights From a Centenarians' Perspective

Fluconazole inhibits human adrenocortical steroidogenesis in vitro

Adrenal Cushing's syndrome during pregnancy

Evaluation of Spheroid 3D Culture Methods to Study a Pancreatic Neuroendocrine Neoplasm Cell Line

Salvage peptide receptor radionuclide therapy with [177Lu-DOTA,Tyr3]octreotate in patients with bronchial and gastroenteropancreatic neuroendocrine tumours

The Pathophysiological Consequences of Somatostatin Receptor Internalization and Resistance

T2-signal intensity, SSTR expression, and somatostatin analogs efficacy predict response to pasireotide in acromegaly

Whole-exome characterization of pancreatic neuroendocrine tumor cell lines BON-1 and QGP-1

Future directions in the diagnosis and medical treatment of adrenocortical carcinoma

Interferon-beta enhances sensitivity to gemcitabine in pancreatic cancer

Peptide receptor radionuclide therapy in patients with medullary thyroid carcinoma: predictors and pitfalls

Long-Term Efficacy and Safety of Pegvisomant in Combination With Long-Acting Somatostatin Analogs in Acromegaly

Vandetanib versus Cabozantinib in Medullary Thyroid Carcinoma: A Focus on Anti-Angiogenic Effects in Zebrafish Model

Epigenetic regulation of SST2 expression in small intestinal neuroendocrine tumors

How to Differentiate Benign from Malignant Adrenocortical Tumors?

Comparing the Effect of Multiple Histone Deacetylase Inhibitors on SSTR2 Expression and [111In]In-DOTATATE Uptake in NET Cells

Effect of epigenetic treatment on SST2 expression in neuroendocrine tumour patients

Reciprocal Interactions between Fibroblast and Pancreatic Neuroendocrine Tumor Cells: Putative Impact of the Tumor Microenvironment

Unfavorable biological behavior and treatment response of neuroendocrine ovarian metastases of midgut neuroendocrine tumors

Influence of type‐I Interferon receptor expression level on the response to type‐I Interferons in human pancreatic cancer cells

Preclinical Evaluation of Novel Tyrosine-Kinase Inhibitors in Medullary Thyroid Cancer

Intra-arterial peptide-receptor radionuclide therapy for neuro-endocrine tumour liver metastases: an in-patient randomised controlled trial (LUTIA)

Effect of the Tryptophan Hydroxylase Inhibitor Telotristat on Growth and Serotonin Secretion in 2D and 3D Cultured Pancreatic Neuroendocrine Tumor Cells

Aktive Filter

Suchergebnisse filtern